Pfizer Q1 2026 Earnings Beat, But Growth Faces Pressure
Pfizer Delivers Strong Q1 Performance Pfizer kicked off 2026 with a better-than-expected first quarter, surpassing Wall Street forecasts on both earnings and revenue. The pharmaceutical giant reported adjusted earnings per share (EPS) of $0.75, beating expectations of $0.72. Revenue came in at $14.45 billion, also ahead of estimates of $13.79 billion. This marks a 5% …